Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400748 · ClinicalTrials.gov registry record · NA
ANET Electrosurgery Applicator Pilot Evaluation Study
A NA study, sponsored by Olympus Corporation of the Americas.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03400748 is a NA study that was terminated before completion, run by Olympus Corporation of the Americas. The registered enrollment target is 6 participants.
The verdict
NCT03400748, a NA study, was terminated before completion, sponsored by Olympus Corporation of the Americas.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Evaluate the preliminary safety and performance of the Electrosurgery Applicator (ANET device) during and after bronchoscopic ablation of a target pulmonary nodule/tumor.
Interventions
- DEVICE RF Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-04-23 |
| Est. Completion | 2020-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03400748
The ClinicalTrials.gov registry entry for NCT03400748 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olympus Corporation of the Americas, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RF Ablation is the first listed.
NCT03400748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03400748 about?
NCT03400748 is a clinical study titled "ANET Electrosurgery Applicator Pilot Evaluation Study". Evaluate the preliminary safety and performance of the Electrosurgery Applicator (ANET device) during and after bronchoscopic ablation of a target pulmonary nodule/tumor.
What is the current status of trial NCT03400748?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2018-04-23. Estimated completion is 2020-11-18.
What interventions are being tested in trial NCT03400748?
The interventions under investigation include: RF Ablation (DEVICE).
Who is sponsoring clinical trial NCT03400748?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.